Cargando…

Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients

BACKGROUND: Metabolic syndrome (MS) and hypovitaminosis D represent two of the most diffuse condition worldwide, reaching pandemic proportions in industrialized countries, and are both strongly associated with obesity. This study set out to evaluate the presence of an independent association between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barchetta, Ilaria, De Bernardinis, Marzia, Capoccia, Danila, Baroni, Marco Giorgio, Fontana, Mario, Fraioli, Antonio, Morini, Sergio, Leonetti, Frida, Cavallo, Maria Gisella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729690/ https://www.ncbi.nlm.nih.gov/pubmed/23935881 http://dx.doi.org/10.1371/journal.pone.0068689

Ejemplares similares

WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity
por: Ceccarelli, Valentina, et al.
Publicado: (2020)

Association of FTO Polymorphisms with Early Age of Obesity in Obese Italian Subjects
por: Sentinelli, Federica, et al.
Publicado: (2012)

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
por: Barchetta, Ilaria, et al.
Publicado: (2019)

Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus
por: Cavallo, Maria Gisella, et al.
Publicado: (2012)

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity
por: Barchetta, Ilaria, et al.
Publicado: (2018)

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
por: Barchetta, Ilaria, et al.
Publicado: (2011)

Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans
por: Bailetti, Diego, et al.
Publicado: (2022)

Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity
por: Cimini, Flavia Agata, et al.
Publicado: (2020)

Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase
por: Barchetta, Ilaria, et al.
Publicado: (2020)

New Insights in the Control of Fat Homeostasis: The Role of Neurotensin
por: Barchetta, Ilaria, et al.
Publicado: (2022)

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
por: Cimini, Flavia A, et al.
Publicado: (2017)

Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease
por: Cimini, Flavia Agata, et al.
Publicado: (2019)

Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study
por: Di Franco, Manuela, et al.
Publicado: (2015)

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Barchetta, Ilaria, et al.
Publicado: (2016)

ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity
por: Bailetti, D., et al.
Publicado: (2018)

The Association of Hypovitaminosis D with the Metabolic Syndrome Is Independent of the Degree of Obesity
por: Miñambres, Inka, et al.
Publicado: (2012)

Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
por: Cimini, Flavia Agata, et al.
Publicado: (2022)

Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization
por: Incani, Michela, et al.
Publicado: (2015)

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy
por: Barchetta, Ilaria, et al.
Publicado: (2020)

High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up
por: Cimini, Flavia Agata, et al.
Publicado: (2021)

Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children
por: Sentinelli, Federica, et al.
Publicado: (2023)

Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes
por: Dule, Sara, et al.
Publicado: (2023)

Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
por: Barchetta, Ilaria, et al.
Publicado: (2022)

Non-invasive tests for fibrosis detection: still in search for the best way
por: Ridola, Lorenzo, et al.
Publicado: (2022)

The Gly482Ser Missense Mutation of the Peroxisome Proliferator-Activated Receptor γ Coactivator-1α (PGC-1α) Gene Associates with Reduced Insulin Sensitivity in Normal and Glucose-Intolerant Obese Subjects
por: Fanelli, Marzia, et al.
Publicado: (2005)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Hypovitaminosis D in Obese and Overweight Schoolchildren
por: Çizmecioğlu, Filiz Mine, et al.
Publicado: (2008)

The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V
por: Bertoccini, Laura, et al.
Publicado: (2017)

Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis
por: Velotti, Francesca, et al.
Publicado: (2020)

Hypovitaminosis
Publicado: (1943)

Hypovitaminosis D in chronic kidney disease
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Role of Hypovitaminosis D in the Pathogenesis of Obesity-Induced Insulin Resistance
por: Greco, Emanuela A., et al.
Publicado: (2019)

Prevalence of hypovitaminosis D and associated factors in obese Spanish children
por: Durá-Travé, T, et al.
Publicado: (2017)

Hypovitaminosis D and Cardiometabolic Risk Factors in Adolescents with Severe Obesity
por: Durá-Travé, Teodoro, et al.
Publicado: (2020)

Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women
por: Abuhijleh, Haya, et al.
Publicado: (2022)

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health
por: Karampela, Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ha0l5bcgqncrdqniom12q4v9c